Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Genetically modified organism wikipedia , lookup
Point mutation wikipedia , lookup
Gene therapy wikipedia , lookup
Molecular ecology wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Genetic code wikipedia , lookup
Clinical neurochemistry wikipedia , lookup
Genetic Screening for Alzheimer’s Disease Thorstensen: Genetic Screening for Alzheimer's Disease 1 What is Alzheimer’s Disease (AD)? Agenda Genes associated with AD The APOE gene Thorstensen: Genetic Screening for Alzheimer's Disease 2 Type of dementia that causes problems with memory, thinking and behavior What is Alzheimer’s Disease (AD)? Most common form of dementia Not a normal part of aging Worsens over time Has no current cure, but treatments for symptoms are available and research continues Thorstensen: Genetic Screening for Alzheimer's Disease 3 AD changes the whole brain Thorstensen: Genetic Screening for Alzheimer's Disease 4 The prime suspects for the cause of cell death and tissue loss are plaques and tangles Thorstensen: Genetic Screening for Alzheimer's Disease 5 Genes associated with AD Four leading genes determined to be causative elements: APP, PS1, PS2 and APOE Mutations in APP, PS1 and PS2 cause early onset AD (younger than 65 years) APOE is a risk factor for late onset AD (older than 65 years) Thorstensen: Genetic Screening for Alzheimer's Disease 6 Present in 30-50% of late onset AD patients Apolipoprotein E The APOE gene Secretory protein Synthesized in the liver Proposed function: Amyloid β aggregation and clearance Intracellular signaling through low-density lipoprotein receptorrelated protein (LRP) Thorstensen: Genetic Screening for Alzheimer's Disease 7 Screening and Evaluation of Deleterious SNPs in the APOE Gene of AD SNP = Single-Nucleotide Polymorphism nsSNP = nonsynonymous SNP Several SNPs present in the APOE gene that serve as biomarkers in exploring the genetic basis of AD Research Goal: Identify deleterious nsSNPs associated with the APOE gene Thorstensen: Genetic Screening for Alzheimer's Disease 8 SNPs are the most common polymorphisms of DNA sequence variation for mapping complex genetic traits 500,000 SNPs in coding regions of human genome Why use SNPs, specifically nsSNPs? Several databases of SNPs nsSNPs cause changes in amino acid residues These mutations are most likely to cause structural changes therefore altering the function of a protein (like APOE plaques and tangles) Thorstensen: Genetic Screening for Alzheimer's Disease 9 Used SNP detection programs I-Mutant, Sort Intolerant from Tolerant (SIFT) and Polymorphism Phenotype (PolyPhen) to detect 88 SNPs on the APOE gene of which 26 were nsSNPs and 5 were deleterious DDG value >-1.0 – least stable Tolerance index of 0.0 – highly deleterious with change in physiochemical properties PSIC score ≥2.0 – probably damaging Thorstensen: Genetic Screening for Alzheimer's Disease 10 Used the Function Analysis and Selection Tool for Single Nucleotide Polymorphisms (FASTSNP) server to detect 7 nsSNPs with high possible functional effects Risk score of 3-4: highly polymorphic Thorstensen: Genetic Screening for Alzheimer's Disease 11 Used the Swiss Protein Data Bank (PDB) viewer to predict mutations in the APOE gene and the Normal Mode Analysis, Deformation, and Refinement (NOMAD-Ref) server to detect 3 mutantstructures with higher total energies and RMSD values compared to the homology modeled structure Deviation in structure implies a functional change Thorstensen: Genetic Screening for Alzheimer's Disease 12 Thorstensen: Genetic Screening for Alzheimer's Disease 13 Must test predicted impact of these nsSNPs using animal models or cell lines to determine if the functionally of the protein has indeed been altered AD has a complex genetic background as well as environmental factors, making research for a cure challenging Thorstensen: Genetic Screening for Alzheimer's Disease 14